Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05135403 · ClinicalTrials.gov registry record
ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)
A clinical trial of Sudden Cardiac Arrest, sponsored by Kestra Medical Technologies.
- Recruiting
- Registry status
- 5,179
- Enrollment target
- 1
- Study location
NCT05135403: Recruiting study of Sudden Cardiac Arrest, sponsored by Kestra Medical Technologies.
NCT05135403 is a study of Sudden Cardiac Arrest that is actively recruiting participants, run by Kestra Medical Technologies. The registered enrollment target is 5,179 participants, above the 1,187-participant average among 8 other Sudden Cardiac Arrest trials with a reported enrollment target (336% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05135403, a study of Sudden Cardiac Arrest, is actively recruiting participants, sponsored by Kestra Medical Technologies.
- RECRUITING
- Registry status
- 5,179 participants
- Enrollment target
- 1
- Study location
Study Summary
Active surveillance study using real-world data collected in the ASSURE Patient Registry. Outcome measures are based on analysis of ASSURE Registry data including data recorded by the WCD then annotated by clinical experts in electrophysiology.
Primary Outcome
Percent of spontaneous episodes of ventricular tachycardia/ventricular fibrillation (VT/VF) successfully converted with one or more shocks ≥ 89.0%
Conditions Studied
Interventions
- DEVICE Defibrillation
Study Locations (1)
Washington
- University of Washington Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,179 participants |
| Start Date | 2021-11-20 |
| Est. Completion | 2025-10-01 |
What NCT05135403 shows while recruiting
NCT05135403 is an observational study that tracks outcomes without assigning an intervention. Its 5,179 participants enrollment target places it among the larger protocols in the corpus, above the 1,187-participant average among 8 other Sudden Cardiac Arrest trials with a reported enrollment target (336% higher).
The record links to 1 condition, with Sudden Cardiac Arrest appearing as the primary indexed condition, and to 1 intervention - of which Defibrillation is the first listed.
NCT05135403 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT05135403 about?
NCT05135403 is a clinical study titled "ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)". Active surveillance study using real-world data collected in the ASSURE Patient Registry. Outcome measures are based on analysis of ASSURE Registry data including data recorded by the WCD then annotated by clinical experts in electrophysiology.
What is the current status of trial NCT05135403?
This trial is currently recruiting. The enrollment target is 5,179 participants. The study started on 2021-11-20. Estimated completion is 2025-10-01.
What conditions does trial NCT05135403 study?
This clinical trial studies the following conditions: Sudden Cardiac Arrest.
What interventions are being tested in trial NCT05135403?
The interventions under investigation include: Defibrillation (DEVICE).
Who is sponsoring clinical trial NCT05135403?
This trial is sponsored by Kestra Medical Technologies, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05135403 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sudden Cardiac Arrest
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05135403's enrollment target sits among peer trials
5,179 1st of 8 higher than 8 of 8 other Sudden Cardiac Arrest trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sudden Cardiac Arrest trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HeartStart HS1 Defibrillator* Event Registry
RECRUITING
-
HS Students Mandatory Universal Student Instruction in CPR Appraised Learning- Is the Mandate Working?
RECRUITING
-
HeartStart FRx Defibrillator Event Registry
RECRUITING
-
Mayo AVC Registry and Biobank
RECRUITING
-
Assessment of Combined CCM and ICD Device in HFrEF
ACTIVE NOT RECRUITING · NA
-
Prediction of ARrhythmic Events With Positron Emission Tomography II
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05989308 · 5,200 participants · NA
MyChart Proxy Outreach to Parents (MyPOP)
- NCT06008197 · 5,200 participants · Phase 3
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- NCT06535867 · 5,122 participants
The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study
- NCT06506344 · 5,250 participants · NA
Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI